Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Patient sues Abbott after early heart valve replacement
The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.
Evoque TTVR system linked to favorable outcomes in new real-world analysis
Researchers tracked data from more than 1,000 real-world patients, focusing on 30-day safety and efficacy outcomes. The group shared its findings at TCT 2025 in San Francisco.
First-in-human data highlight IVL’s potential to treat more challenging lesions
Shockwave Medical and FastWave Medical have shared new first-in-human data on their advanced IVL offerings. Both companies are focused on addressing difficult-to-cross lesions that often cause problems for cardiologists.
Medicare now covers renal denervation for patients with uncontrolled hypertension
This decision expands access to renal denervation to many more patients throughout the United States. Recor Medical and Medtronic both gained FDA approval for their RDN systems in 2023, and other vendors are actively developing their own treatment options.

Early research suggests the wearable device can deliver consistent measurements, providing accuracy where other methods have struggled.

The lack of cooperation may be hindering efforts to rein in cancer costs and improve affordability, oncology experts explained recently.

“The findings of this study highlight the need for strategies to reduce and manage the burden of false-positive ILR alerts,” the researchers said.

This was the first analysis of the risk of ICH in patients with AFib taking different oral anticoagulants.

While rare, these instances may represent “major” clinical findings and necessitate additional imaging, rad oncology experts urged.

The administration said it studied the vaccine's safety in more than 3,100 children, and no serious side effects have been reported thus far.

Researchers emphasized that safety considerations should be included when stimulants are prescribed to older adults.

The new guidelines stress the importance of more complete chest pain evaluations, patient communication and shared decision-making.